Gilead posts ARTISTRY-2 results; registers GS-1179 herpes trial and ARTISTRY-3 HIV studyNov 5Weekly roundup, 4 itemsbictegravirbictegravir/lenacapavirUpdated
Merck posts Q3 2026 results with oncology approvals and new sac-TMT regulatory filingOct 29Quarterly updateGilead SciencesMerck & Co., Inc.
Gilead-linked filings: ARTISTRY-1, KeY Treat post results; iMMagine-4 registers at KiteOct 23Weekly roundup, 4 itemsanitocabtagene autoleucelbictegravirUpdated
Sign inSign in